Solventum (SOLV)Sen. Alan Armstrong disclosed a purchase $1K–$15K

$1,001–$15,000

Reported range · official band, not an exact amount

116 days

Disclosure lag

Traded

Mar 27, 2026

Disclosed

Jul 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jan 27, 20265% stakeIndependent Franchise Partners, LLP reported a passive stake (13G) of 8.8%
2. Feb 26, 2026Company filing · Form 8-K · ResultsReported its results
3. Mar 10, 2026Insider · 10 days before an 8-KDirector purchased ~$100K of SOLV shares in the open market
4. Mar 13, 2026FDAFDA device clearance: Promogran Prisma™ Collagen Matrix with ORC and Silver
5. Mar 20, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 20, 2026, Mary Wilcox informed Solventum Corporation (the “Company”) of her intent to retire and resign from her position as Chief Accounting Officer of the Company following a search for and appointment of her successor.”
6. Mar 27, 2026 · this disclosureCongressDisclosed purchase of SOLV — reported range $1,001 - $15,000

What came next

1. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
2. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 6.3%
3. May 5, 2026Company filing · Form 8-K · ResultsReported its results
4. May 21, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 21, 2026, the Talent Committee (the “Committee”) of the Board of Directors of Solventum Corporation (the “Company”) adopted and approved the Solventum Executive Severance Plan and Summary Plan Description (the “Severance Plan”), effective June 1, 2026.”
5. Jul 16, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 16, 2026, the Board of Directors of Solventum Corporation (the “Company”) appointed Neil Zieselman to serve as Senior Vice President, Controller and Chief Accounting Officer of the Company, effective as of August 10, 2026.”

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Solventum

For Solventum, OQRO holds 2 Congress trade reports and 4 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SOLV page.

Other recent filings by Sen. Alan Armstrong

• Senate eFD periodic transaction report at Williams Companies (WMB)Sep 17, 2026
• Senate eFD periodic transaction report at Williams Companies (WMB)Sep 17, 2026
• Senate eFD periodic transaction report at KKR & Co. (KKR)Jul 21, 2026
• Senate eFD periodic transaction report at Globe Life (GL)Jul 21, 2026
• Senate eFD periodic transaction report at Copart (CPRT)Jul 21, 2026

The full history of Sen. Alan Armstrong is on the profile page.

How this filing works

• The STOCK Act

Other disclosures at Solventum

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 13, 2026
• SEC Form 13F-HRAug 7, 2026
• SEC Form 13F-HRAug 6, 2026
• Senate eFD periodic transaction reportAug 5, 2026
• SEC Form 13F-HRJul 10, 2026

Everything OQRO holds on this company is on its SOLV page.